Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Lindora Celebrates 55 Years With Accelerated National Growth and New Clinics in Colorado, Tennessee, North Carolina, and Arizona
-
Match Group to Announce Third Quarter 2026 Results
-
Link Logistics Acquires Fully Leased Bulk Distribution Facility in Raleigh
-
Flotek Announces Third Quarter 2026 Earnings Release and Conference Call Schedule
-
NOG Provides Third Quarter Operational Update
-
Custom Truck One Source Announces Third Quarter 2026 Earnings Release and Conference Call
-
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
-
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
-
Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
-
Greenbrier schedules fourth quarter fiscal 2026 earnings release and conference call
-
Gen to Participate in Upcoming Investor Conferences
-
Noble Corporation plc to announce third quarter 2026 results
-
MYR Group Inc. to Attend Cantor Convergence: 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference in November
-
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
-
TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn's disease
-
Onto Innovation Receives Best Partner Award from SK hynix for Hidden Defect Prevention in High Bandwidth Memory Production
-
AB Announces September 30, 2026 Assets Under Management
-
Solaris Energy Infrastructure Schedules Third Quarter 2026 Results Conference Call
-
Penguin Solutions Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Nextpower to Hold Capital Markets Day on November 16, 2026
-
Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2026
-
Deckers Brands Announces Conference Call to Review Second Quarter Fiscal 2027 Earnings Results
-
New TREMFYA® (guselkumab) study shows consistent perianal fistula remission across key Crohn's disease patient subgroups
-
Palantir Announces Date of Third Quarter 2026 Earnings Release and Webcast
-
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
-
Intellicheck and DESKO to Showcase Biometric Desktop Identity Verification at Money20/20 Las Vegas
-
Bandwidth to Report Third Quarter 2026 Financial Results on October 29, 2026
-
Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
-
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Agilysys to Report Fiscal 2027 Second Quarter Results October 26th and Host Conference Call and Webcast
-
Clearwater Paper Announces Availability and Timing of Third Quarter 2026 Earnings Conference Call and Webcast
-
International Paper Declares Quarterly Dividend
-
Howard Hughes Holdings Inc. Announces Dates and Times for 2026 Third Quarter Earnings Release and Conference Call
-
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
-
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
-
Healthcare Realty Trust Releases Eighth Corporate Responsibility Report
-
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
-
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
-
Upwork to Report Third Quarter Financial Results on November 2, 2026
-
Cerro de Pasco Resources Awarded the Quiulacocha Tailings in AMSAC Public Bidding Process
-
FormFactor and Teradyne Announce Strategic Collaboration to Accelerate Next-Generation Semiconductor Testing
-
ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002
-
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results
-
Syndax Announces Topline Results from MAXPIRe Phase 2 Trial of Axatilimab in Idiopathic Pulmonary Fibrosis
-
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
-
NewHydrogen to Release a Special Report on October 19, 2026
-
Fermi Announces Third Quarter 2026 Earnings Release and Call Date
-
Cytokinetics Announces Additional Data from ACACIA-HCM Presented at the HFSA Annual Scientific Meeting 2026
-
Shutterstock To Report Third Quarter 2026 Earnings Results on November 5, 2026
